Accessibility Menu
Medical Developments International logo

Medical Developments International(OTC) MDDVF

Market Cap$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-95%
5 Year-93%
1 Year+4%
1 Month-10%
$0.33
+0.00%
+0.00Today
Medical Developments International last closing stock price
MetricPriceDate
Last closeUSD 0.332026-08-10
Medical Developments International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.61%USD 0.372026-05-06
1 month-9.61%USD 0.372026-05-06
3 month-9.61%USD 0.372026-05-06
Year to date+10.09%USD 0.302025-12-17
1 year+4.32%USD 0.322025-06-26
3 year-41.68%USD 0.572023-05-08
5 year-93.31%USD 5.002021-07-19
Since inception-94.84%USD 6.482020-01-21

Medical Developments International Financials at a Glance

Market Cap

$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$81.59M

Net Income (TTM)

A$718.90K

EPS (TTM)

$0.00

P/E Ratio

83.62

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.33

Volume

2,500

Open

$0.33

Previous Close

$0.33

Daily Range

$0.33 - $0.33

52-Week Range

$0.30 - $0.37

Estimated Earnings Date

Feb 25, 2027

MDDVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medical Developments International

Medical Developments International Limited is a global provider of essential medical solutions, engaged in both manufacturing and distribution. The company operates primarily in two segments: Pain Management and Respiratory, offering innovative products to improve patient care.

Products and Services
  • Penthrox, a pain relief product for trauma and emergency situations
  • Devices for asthma and chronic obstructive pulmonary disease management
  • Diverse medical instruments, including CPR equipment and oxygen therapy kits
Growth Outlook
  • Recent quarterly revenue reached AUD 20.97 million, indicating strong market demand
  • Gross profit margin improved to 25% in the latest quarter, reflecting operational efficiency
  • Current ratio of 5.77 suggests robust liquidity and financial health
Financial Highlights
  • Net income for the latest quarter was AUD 850,806, showcasing profitability
  • Trailing twelve months (TTM) revenue stands at AUD 82.5 million, demonstrating consistent growth
  • Operating cash flow per share of AUD 0.051 indicates strong cash generation capabilities
Medical Developments International Limited has established itself as a key player in the healthcare sector, focusing on innovative solutions for pain management and respiratory care. The company's flagship product, Penthrox, is widely recognized for its effectiveness in emergency medical situations. With a strong presence in Australia, Europe, and the United States, the company is well-positioned to capitalize on the growing demand for medical solutions globally. Recent financial performance highlights a positive trajectory, with increasing revenue and profitability, making it an intriguing option for potential investors interested in the healthcare industry.
AI Generated • Aug 26, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Brent MacGregor, MBA

Website

www.medicaldev.com

Headquarters

Scoresby, VIC 3179, AU

MDDVF Financials

Key Financial Metrics (TTM)

Gross Margin

28.15%

Operating Margin

2.48%

Net Income Margin

1.47%

Return on Equity

1.13%

Return on Capital

1.84%

Return on Assets

0.91%

Earnings Yield

1.20%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

112.66M

Volume

2.50K

Avg. Volume

39.063

Financials (TTM)

Gross Profit

A$41.40M

Operating Income

A$4.13M

EBITDA

A$7.08M

Operating Cash Flow

A$5.70M

Capital Expenditure

-A$923.55K

Free Cash Flow

A$4.78M

Cash & ST Invst.

A$21.34M

Total Debt

A$1.66M

Medical Developments International Performance Analysis

Medical Developments International annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 21,753,24636.7%
20242024-06-30AUD 21,725,027-0.1%
20252025-06-30AUD 25,293,87616.4%
20262026-06-30AUD 28,845,05314.0%
Medical Developments International sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3110.6%
Q42025-06-30-4.6%
Q22025-12-3113.1%
Q42026-06-30-2.8%
Medical Developments International annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.04-64.0%
20242024-06-30AUD -0.30595.4%
20252025-06-30AUD 0.00N/A
20262026-06-30AUD 0.00620.0%
Medical Developments International sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31100.8%
Q42025-06-30-170.4%
Q22025-12-31N/A
Q42026-06-30489.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$20.97M

+16.1%

Gross Profit

A$5.26M

+78.1%

Gross Margin

25.08%

N/A

Market Cap

$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$554.11K

N/A

Employees

68

N/A

Net Income

A$850.81K

+102.8%

EBITDA

A$2.41M

+113.2%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$21.34M

+119.2%

Total Debt

A$1.66M

-27.2%

Accounts Receivable

A$6.69M

-5.4%

Inventory

A$6.94M

-20.8%

Long Term Debt

A$1.32M

-31.0%

Short Term Debt

A$342.52K

-7.7%

Return on Assets

0.91%

N/A

Return on Invested Capital

1.69%

N/A

Free Cash Flow

A$5.20M

+188.4%

Operating Cash Flow

A$5.46M

+226.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LEEEFLeef Brands Inc.
$0.19+0.00%
SEOVFSernova Corp.
$0.08+0.00%
ITHUFiAnthus Capital Holdings, Inc.
$0.00-20.00%
DSOLDrug Free Solution, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.34-0.10%
NOKNokia
$10.03+0.03%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$117.28+0.10%
INTCIntel
$95.80+0.05%

Questions About MDDVF

What is the current price of Medical Developments International?

Medical Developments International is trading at $0.33 per share.

What is the 52-week range for Medical Developments International?

Over the past 52 weeks, Medical Developments International has traded between $0.30 and $0.37.

How much debt does Medical Developments International have?

As of the most recent reporting period, Medical Developments International reported total debt of A$1.15M.

How much cash does Medical Developments International have on hand?

Medical Developments International reported A$9.95M in cash and cash equivalents in its most recent financial results.

What is Medical Developments International’s dividend yield?

Medical Developments International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services